Opportunity
SAM #75N98026Q00214
Sole Source Procurement: Insulated-Sensing Myocardial Navigation Guidewire Prototypes and Engineering Services
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
April 16, 2026
Respond By
April 28, 2026
Identifier
75N98026Q00214
NAICS
541714, 339112, 541715
The National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) is planning a sole source procurement for advanced insulated-sensing intramyocardial electrosurgical guidewire prototypes and related engineering services. - Government Buyer: - National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) - OEMs and Vendors: - Resonetics (sole source intended contractor) - Products/Services Requested: - Approximately 10-20 insulated-sensing intramyocardial electrosurgical guidewire prototypes - 0.014-inch insulated electrosurgical guidewire - Capabilities: controlled myocardial tissue traversal, electrogram sensing, electroanatomic mapping, radiofrequency ablation - For preclinical in vivo animal laboratory evaluation - Engineering development and technical support services - Mechanical and electrical design, insulation strategy, prototype fabrication, bench validation, iterative refinement, and in vivo animal testing support - Unique or Notable Requirements: - Prototypes must meet specific mechanical and electrical performance criteria for preclinical evaluation - Delivery of prototypes required within 10-15 weeks post-award - Sole source to Resonetics; capability statements from other parties may be considered - Place of Performance and Delivery: - National Heart, Lung, and Blood Institute (NHLBI), Building 10, Room 2C713, 10 Center Drive, Bethesda, MD 20892
Description
The National Heart, Lung, and Blood Institute (NHLBI) intends to award a sole source contract for the design, fabrication, and testing of insulated-sensing intramyocardial electrosurgical guidewire prototypes. The effort includes engineering development, bench validation, and delivery of refined prototypes for preclinical in vivo evaluation. This Notice of Intent is not a request for competitive proposals; however, interested parties may submit capability statements for consideration.